Collectively, our proteomics, transcriptomics, and ubiquitinomics data suggest that PF-3758309 inhibits tumor growth by regulating the ubiquitination-dependent degradation of POLR2A/B/E. This evidence concerns the gene POLR2A and neoplasm.